Update on treatment of menstrual disorders.
Eizenberg
David H
DH
D000328:Adult; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000191:economics; D003362:Cost-Benefit Analysis; D004621:Embolization, Therapeutic / Q000009:adverse effects; D005260:Female; D006801:Humans; D007045:Hysterectomy, Vaginal / Q000191:economics; D007436:Intrauterine Devices, Medicated / Q000191:economics; D007889:Leiomyoma / Q000150:complications / Q000628:therapy; D016912:Levonorgestrel / Q000008:administration & dosage / Q000191:economics; D008595:Menorrhagia / Q000150:complications / Q000628:therapy; D008599:Menstruation Disturbances / Q000628:therapy*; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000150:complications / Q000628:therapy
D003271:Contraceptive Agents, Female; D016912:Levonorgestrel